Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Expert Opinion on Therapeutic Patents
|
December 20, 2024
WD repeat domain 5 (WDR5) inhibitors: a patent review (2016-present)
Jesse A Coker, Shaun R Stauffer
Journal of Natural Products
|
March 12, 2016
Sclerotiamide: The First Non-Peptide-Based Natural Product Activator of Bacterial Caseinolytic Protease P
Nathan P Lavey, Jesse A Coker, Eliza A Ruben, et al.
Journal of Medicinal Chemistry
|
July 17, 2020
Discovery of Sulfonamide-Derived Agonists of SOS1-Mediated Nucleotide Exchange on RAS Using Fragment-Based Methods
Dhruba Sarkar, Edward T Olejniczak, Jason Phan, et al.
ACS Chemical Biology
|
February 16, 2026
Fragment-Based Development of NSP14 Exonuclease Inhibitors Confounded by Batch-to-Batch Variability
Jesse A Coker, Rong Sun, Paul M Polzer, et al.
Biorxiv : the Preprint Server for Biology
|
September 5, 2025
MCL1 may not mediate chemoresistance
Kylin A Emhoff, Kunho Chung, Dongmei Zhang, et al.
ACS Medicinal Chemistry Letters
|
November 21, 2017
Consequences of Depsipeptide Substitution on the ClpP Activation Activity of Antibacterial Acyldepsipeptides
Yangxiong Li, Nathan P Lavey, Jesse A Coker, et al.
Biorxiv : the Preprint Server for Biology
|
July 17, 2025
Mechanism and Structure-Guided Optimization of SLC1A1/EAAT3-Selective Inhibitors in Kidney Cancer
Pooneh Koochaki, Biao Qiu, Jesse A Coker, et al.
Biorxiv : the Preprint Server for Biology
|
April 10, 2026
METTL16 promotes taxane resistance in Triple-Negative Breast Cancer through m <sup>6</sup> A-dependent translational upregulation of ABCB1
Elise G Holvey-Bates, Jesse A Coker, Daniel J Lindner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 25, 2024
CDK9 Inhibition by Dinaciclib Is a Therapeutic Vulnerability in Epithelioid Hemangioendothelioma
Ajaybabu V Pobbati, Ashley Burtscher, Nandini Rajaram Siva, et al.
The EMBO Journal
|
April 22, 2026
Structure-guided optimization of SLC1A1/EAAT3-selective inhibitors targeting renal cancer metabolism
Pooneh Koochaki, Biao Qiu, Jesse A Coker, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Expert Opinion on Therapeutic Patents
|
December 20, 2024
WD repeat domain 5 (WDR5) inhibitors: a patent review (2016-present)
Jesse A Coker, Shaun R Stauffer
Journal of Natural Products
|
March 12, 2016
Sclerotiamide: The First Non-Peptide-Based Natural Product Activator of Bacterial Caseinolytic Protease P
Nathan P Lavey, Jesse A Coker, Eliza A Ruben, et al.
Journal of Medicinal Chemistry
|
July 17, 2020
Discovery of Sulfonamide-Derived Agonists of SOS1-Mediated Nucleotide Exchange on RAS Using Fragment-Based Methods
Dhruba Sarkar, Edward T Olejniczak, Jason Phan, et al.
ACS Chemical Biology
|
February 16, 2026
Fragment-Based Development of NSP14 Exonuclease Inhibitors Confounded by Batch-to-Batch Variability
Jesse A Coker, Rong Sun, Paul M Polzer, et al.
Biorxiv : the Preprint Server for Biology
|
September 5, 2025
MCL1 may not mediate chemoresistance
Kylin A Emhoff, Kunho Chung, Dongmei Zhang, et al.
ACS Medicinal Chemistry Letters
|
November 21, 2017
Consequences of Depsipeptide Substitution on the ClpP Activation Activity of Antibacterial Acyldepsipeptides
Yangxiong Li, Nathan P Lavey, Jesse A Coker, et al.
Biorxiv : the Preprint Server for Biology
|
July 17, 2025
Mechanism and Structure-Guided Optimization of SLC1A1/EAAT3-Selective Inhibitors in Kidney Cancer
Pooneh Koochaki, Biao Qiu, Jesse A Coker, et al.
Biorxiv : the Preprint Server for Biology
|
April 10, 2026
METTL16 promotes taxane resistance in Triple-Negative Breast Cancer through m <sup>6</sup> A-dependent translational upregulation of ABCB1
Elise G Holvey-Bates, Jesse A Coker, Daniel J Lindner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 25, 2024
CDK9 Inhibition by Dinaciclib Is a Therapeutic Vulnerability in Epithelioid Hemangioendothelioma
Ajaybabu V Pobbati, Ashley Burtscher, Nandini Rajaram Siva, et al.
The EMBO Journal
|
April 22, 2026
Structure-guided optimization of SLC1A1/EAAT3-selective inhibitors targeting renal cancer metabolism
Pooneh Koochaki, Biao Qiu, Jesse A Coker, et al.
Page
of 2